Note to Industry on Requirement for Bioequivalence Study
Bioequivalence (BE) study is a clinical trial designed to demonstrate that two pharmaceutical products, typically a generic drug and its corresponding reference innovator brand have similar bioavailability and efficacy hence, interchangeable healthcare practices. Over 90% of drug products used in the country are generics with which access and affordability is created without compromising quality. Presently, […]
Public Alert No. 043/2024 – Alert on the Sale of Counterfeit COMBIART (Artemether + Lumefantrine 20/120mg) Dispersible Tablet in Nigeria
The National Agency for Food and Drugs Administration and Control (NAFDAC) is writing to inform the public about the circulation of counterfeit Combiart Dispersible Tablet 20/120mg in the country. The product is manufactured by Strides Arcolab Limited, based in India. This product was discovered in the FCT and Rivers State, during surveillance activities conducted by […]
NAFDAC List of Recognized Standards for Medical Devices
This is to inform the public of the National Agency for Food and Drug Administration and Control (NAFDAC) list of recognized standards for medical devices including in vitro diagnostics. Click to download Was this helpful? Yes No Submit Cancel Thanks for your feedback!
